The technology to read the live record
From records to intelligence.
Our system organizes, interprets, and verifies the public record.
Atlas
Holds the domain taxonomy: entity types, the statement types that attach to them, and the threshold at which a change becomes material.
ConteXt
Compares the record with prior versions, the entity’s history and related records, and returns a classification with the evidence used to reach it.
Ledger
Checks each classification against the source document, records version and time, corrects errors in place, and scores the determination when the outcome is known.
| Entities | 412 |
| Claims | 288 |
| Commitments | 196 |
| Events | 243 |
| States | 167 |
| Outcomes | 106 |
- Third move on primary completion date in 14 months
- Corvane slipped 4 of its last 6 phase 3 trials
- Enrollment figure unchanged for 9 months
- Two sites removed in the same revision
| Field | Primary completion date |
| Source | Registry record v7 |
| Checked | 14 May, 09:41 ET |
| Corrected | 14 May, 09:44 ET |
| Scores | On readout |
All four products read the same verified determinations. They differ in timing and aggregation, not in underlying data.
Signals
Corvane pushes CVN‑401 phase 3 completion to September
The second-line lung cancer trial’s primary completion date moved from 15 March to 30 September 2026, six months later than filed.
Third slip in 14 months. Four of Corvane’s last six phase 3 trials have moved.
Indicators
Share of active phase 3 trials whose primary completion date moved in the trailing 90 days.
Forecasts
Resolutions
14 Apr 2027
Meridian’s MRD‑217 approved three days early. Label restricted to second-line use.